Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of -0.33 is 100% above its 5-year average of -510.63, near the high end of its 5-year range (-2889.06–-0.32).
68.12% above its 12-month average of -1.03.
Reported quarterly EPS; no daily interpolation. Q4 FY2026 (2026-06-30): -0.06.
EPS growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
FMP quote price / unrounded diluted EPS from four consecutive issuer fiscal quarters Quote observation: 2026-10-06T14:42:15.713Z. Historical observations retain their original dates. Historical series through 2014-11-14.
EARNINGS PER SHARE (EPS)
-0.33
EARNINGS PER SHARE (EPS) AVG TTM
-1.03
EARNINGS PER SHARE (EPS) AVG 3Y
-28.69
EARNINGS PER SHARE (EPS) AVG 5Y
-510.63
EARNINGS PER SHARE (EPS) AVG 10Y
-546.37
EARNINGS PER SHARE (EPS) AVG 15Y
-372.93
EARNINGS PER SHARE (EPS) AVG 20Y
-376.17
CURRENT VS TTM AVG
+68.12%
CURRENT VS 3Y AVG
+98.85%
CURRENT VS 5Y AVG
+99.94%
CURRENT VS 10Y AVG
+99.94%
CURRENT VS 15Y AVG
+99.91%
CURRENT VS 20Y AVG
+99.91%
iBio, Inc.
Market Cap
$68.49M
Earnings Per Share (EPS)
-0.33
TTM Avg
-1.03
3Y Avg
-28.69
5Y Avg
-510.63
Market Cap
$69.26M
Earnings Per Share (EPS)
-0.08
TTM Avg
0.13
3Y Avg
-0.17
5Y Avg
-0.10
Market Cap
$67.60M
Earnings Per Share (EPS)
2.68
TTM Avg
-1.38
3Y Avg
-6.44
5Y Avg
-7.90
Market Cap
$65.59M
Earnings Per Share (EPS)
-5.01
TTM Avg
-7.16
3Y Avg
-89.38
5Y Avg
-71.00
Market Cap
$71.89M
Earnings Per Share (EPS)
-0.26
TTM Avg
-0.44
3Y Avg
-0.60
5Y Avg
-0.58
Market Cap
$64.94M
Earnings Per Share (EPS)
-0.19
TTM Avg
-0.10
3Y Avg
-0.67
5Y Avg
-1.24
Market Cap
$64.56M
Earnings Per Share (EPS)
-55.66
TTM Avg
-39.81
3Y Avg
-97.72
5Y Avg
-154.19
Market Cap
$64.31M
Earnings Per Share (EPS)
-0.64
TTM Avg
-0.89
3Y Avg
-1.15
5Y Avg
-1.02
Market Cap
$72.73M
Earnings Per Share (EPS)
-0.50
TTM Avg
-0.75
3Y Avg
-1.17
5Y Avg
-1.06
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| iBio, Inc. (IBIO) | $68.49M | -0.33 | -1.03 | -28.69 | -510.63 |
| Champions Oncology, Inc. (CSBR)vs › | $69.26M | -0.08 | 0.13 | -0.17 | -0.10 |
| Fortress Biotech, Inc. (FBIO)vs › | $67.60M | 2.68 | -1.38 | -6.44 | -7.90 |
| Cingulate Inc. (CING)vs › | $65.59M | -5.01 | -7.16 | -89.38 | -71.00 |
| MindWalk Holdings Corp. (HYFT)vs › | $71.89M | -0.26 | -0.44 | -0.60 | -0.58 |
| Heron Therapeutics, Inc. (HRTX)vs › | $64.94M | -0.19 | -0.10 | -0.67 | -1.24 |
| Gossamer Bio, Inc. (GOSS)vs › | $64.56M | -55.66 | -39.81 | -97.72 | -154.19 |
| PDS Biotechnology Corporation (PDSB)vs › | $64.31M | -0.64 | -0.89 | -1.15 | -1.02 |
| Gain Therapeutics, Inc. (GANX)vs › | $72.73M | -0.50 | -0.75 | -1.17 | -1.06 |
| Alps Group Inc (ALPS)vs › | $64.05M | N/A | -0.02 | -0.02 | -0.01 |
Trailing EPS (TTM)
$-0.33
Forward EPS (Est.)
$-0.37
P/E Ratio
N/A
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2026-06-30 | -0.32 |
| 2025-06-30 | -1.75 |
| 2024-06-30 | -6.50 |
| 2023-06-30 | -106.18 |
| 2022-06-30 | -2889.06 |
| 2021-06-30 | -59.98 |
| 2020-06-30 | -304.64 |
| 2019-06-30 | -471.65 |
| 2018-06-30 | -770.00 |
| 2017-06-30 | -800.00 |
| 2016-06-30 | -600.00 |
| 2015-06-30 | -450.00 |
| 2014-06-30 | -300.00 |
| 2013-06-30 | -650.00 |
| 2012-06-30 | -700.00 |
| 2011-06-30 | -1950.00 |
| 2010-06-30 | -1100.00 |
| 2009-06-30 | -450.00 |
| 2008-06-30 | 0.00 |
| 2007-06-30 | 0.00 |
